Menu

Blog

Dec 12, 2023

CRSP Stock On Wild Ride After FDA’s Historic Approval. These Gene Editing Treatments Could Be Next

Posted by in categories: bioengineering, biotech/medical

Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using CRISPR technology to treat sickle cell disease. Gove…

Comments are closed.